PropertyValue
?:abstract
  • The coronavirus disease 2019 (COVID-19) has become a global pandemic, which is induced by infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Patients with systemic lupus erythematosus (SLE) are susceptible to infections due to the chronic use of immunosuppressive drugs and the autoimmune disorders. Now we report a case of SLE infected with SARS-CoV-2, influenza A virus and Mycoplasma pneumoniae concurrently. The patient used hydroxychloroquine and prednisone chronically to control the SLE. After infection of SARS-CoV-2, she was given higher dose of prednisone than before and the same dosage of hydroxychloroquine. Besides, some empirical treatments such as antiviral, antibiotic and immunity regulating therapies were also given. The patient finally recovered from COVID-19. This case indicated that hydroxychloroquine may not be able to fully protect SLE patient form SARS-CoV-2. Intravenous immunoglobulin therapies and increased dose of corticosteroids might be adoptable for patient with both COVID-19 and SLE. Physicians should consider SARS-CoV-2 virus test when SLE patient presented with suspected infection or SLE flare under the epidemic of COVID-19.
is ?:annotates of
?:creator
?:doi
?:doi
  • 10.1515/med-2020-0238
?:journal
  • Open_Med_(Wars)
?:license
  • cc-by
?:pdf_json_files
  • document_parses/pdf_json/b46e99179e634f64baeb55c901f6aa218dc1a3b3.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7718649.xml.json
?:pmcid
?:pmid
?:pmid
  • 33336061.0
?:publication_isRelatedTo_Disease
is ?:relation_isRelatedTo_publication of
?:sha_id
?:source
  • Medline; PMC
?:title
  • A case of SLE with COVID-19 and multiple infections
?:type
?:year
  • 2020-10-14

Metadata

Anon_0  
expand all